0310-1730 : Fasenra 30 mg/ml Subcutaneous Injection, Solution


NDC: 0310-1730
Labeler: Astrazeneca Pharmaceuticals Lp
Product Type: Human Prescription Drug
Drug Name:  Fasenra
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA761070
Rev. Date: 


NDC Package Codes:

  • 0310-1730-30: 1 SYRINGE, GLASS IN 1 CARTON (0310‑1730‑30) > 1 ML IN 1 SYRINGE, GLASS
  • 0310-1730-85: 1 SYRINGE, GLASS IN 1 CARTON (0310‑1730‑85) > 1 ML IN 1 SYRINGE, GLASS

Active Ingredients:

  • Benralizumab

Dosage Strength:

  • 30 mg/mL

Pharmaceutical Classes:

  • Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]
  • Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]

Related Products:

Based on records with the same trade name.
  • 0310-1745 Fasenra 10 mg/.5ml Subcutaneous Injection, Solution by Astrazeneca Pharmaceuticals Lp
  • 0310-1830 Fasenra 30 mg/ml Subcutaneous Injection, Solution by Astrazeneca Pharmaceuticals Lp

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0310-1730 QR Code

< Prev: 0310-1475Next: 0310-1745 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.